Correlation Between Spyre Therapeutics and NioCorp Developments
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and NioCorp Developments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and NioCorp Developments into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and NioCorp Developments Ltd, you can compare the effects of market volatilities on Spyre Therapeutics and NioCorp Developments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of NioCorp Developments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and NioCorp Developments.
Diversification Opportunities for Spyre Therapeutics and NioCorp Developments
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Spyre and NioCorp is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and NioCorp Developments Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NioCorp Developments and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with NioCorp Developments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NioCorp Developments has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and NioCorp Developments go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and NioCorp Developments
Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 0.87 times more return on investment than NioCorp Developments. However, Spyre Therapeutics is 1.15 times less risky than NioCorp Developments. It trades about 0.02 of its potential returns per unit of risk. NioCorp Developments Ltd is currently generating about -0.14 per unit of risk. If you would invest 2,837 in Spyre Therapeutics on September 3, 2024 and sell it today you would earn a total of 6.00 from holding Spyre Therapeutics or generate 0.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spyre Therapeutics vs. NioCorp Developments Ltd
Performance |
| Timeline |
| Spyre Therapeutics |
| NioCorp Developments |
Spyre Therapeutics and NioCorp Developments Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and NioCorp Developments
The main advantage of trading using opposite Spyre Therapeutics and NioCorp Developments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, NioCorp Developments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NioCorp Developments will offset losses from the drop in NioCorp Developments' long position.| Spyre Therapeutics vs. DiaMedica Therapeutics | Spyre Therapeutics vs. Lyra Therapeutics | Spyre Therapeutics vs. Centessa Pharmaceuticals PLC |
| NioCorp Developments vs. Summit Materials | NioCorp Developments vs. Westrock Coffee | NioCorp Developments vs. Aldel Financial II | NioCorp Developments vs. Keurig Dr Pepper |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |